Kilian Kelly Insider Profile
4 Followers
Kilian Kelly, Director at Cynata Therapeutics Limited, holds 1.06M shares in Cynata Therapeutics Limited (Ticker: CYYNF). Most recently, Kilian Kelly Bought 265,703 shares of Cynata Therapeutics Limited on Nov 03, 2026 for an estimated value of $2.66K.
Kilian Kelly's Trading History
| CYYNFCynata Therapeutics Limited | Nov 03, 2026 | Director | Informative Buy | 2.66K | $236.02K | |||||||||||||||||||||||||||||
CYYNF Insider Shares: 1.06M (43.67%)
| ||||||||||||||||||||||||||||||||||
You May Also Like
Kilian Kelly insider profile FAQ
What is the percentage of profitable transactions made by Kilian Kelly?
The percentage of profitable transactions made by Kilian Kelly is 100%.
What is the average return per transaction made by Kilian Kelly?
The average return per transaction made by Kilian Kelly is 86.20%.
What stocks does Kilian Kelly hold?
Kilian Kelly holds: CYYNF stocks.
What was Kilian Kelly’s latest transaction?
Kilian Kelly’s latest transaction was an Informative Buy of $2.66K.
What was Kilian Kelly's most profitable transaction?
Kilian Kelly’s most profitable transaction was an Informative Buy of CYYNF stock on November 22, 2023. The return on the trade was 163.80%.
What is Kilian Kelly's role in Cynata Therapeutics Limited?
Kilian Kelly's role in Cynata Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
